CCR8 Antibody (191704) [Biotin]
Novus Biologicals, part of Bio-Techne | Catalog # FAB1429B
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
CyTOF-ready, Flow Cytometry, Neutralization
Label
Biotin
Antibody Source
Monoclonal Rat IgG2B Clone # 191704
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
BaF3 mouse pro-B cell line transfected with human CCR8
Met1-Leu355
Accession # P51685
Met1-Leu355
Accession # P51685
Specificity
Detects human CCR8. Neutralizes the bioactivity of human CCR8 and specifically stains human CCR8-transfected cell lines but not with the parent cell lines.
Clonality
Monoclonal
Host
Rat
Isotype
IgG2B
Applications for CCR8 Antibody (191704) [Biotin]
Application
Recommended Usage
CyTOF-ready
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Neutralization
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from hybridoma culture supernatant
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: CCR8
Alternate Names
CCR8, CD198, CDw198, ChemR1, CKRL1, GPRCL1, TER-1
Gene Symbol
CCR8
Additional CCR8 Products
Product Documents for CCR8 Antibody (191704) [Biotin]
Product Specific Notices for CCR8 Antibody (191704) [Biotin]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...